Literature DB >> 9679938

Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier.

J C Nickel1, J Downey, A Morales, L Emerson, J Clark.   

Abstract

PURPOSE: To investigate the relative efficacy of heparin (H), pentosanpolysulfate (PPS) and hyaluronic acid (HA) in preventing the absorption of 14C labeled urea in protamine pretreated bladders compared with saline pretreated control bladders.
MATERIALS AND METHODS: Control Group - Rabbit bladders were pretreated with phosphate buffered saline (PBS) followed by instillation of 14C-urea. Radioactivity was determined in blood, bladder and fluid drained from the bladder. Protamine Group - Bladders were pretreated with of PBS followed by protamine sulfate. The bladders were then treated with 14C-urea and radioactivity determined as above. GAG Groups - Bladders were pretreated with saline and protamine as described above followed by instillation of: Group 3A - HA, Group 3B - H and Group 3C - PPS. The bladders were then treated with 14C-urea and radioactivity determined as described above.
RESULTS: Protamine treated bladders demonstrated significantly more radioligand uptake in bladder tissue compared with control bladders. There was no significant difference in radioligand uptake in bladders treated with PPS and H compared with control. While not significantly different, there was considerably more radioligand concentration in the blood of rabbits with bladders treated with protamine and protamine-HA compared with those of control rabbits and those treated with protamine-PPS and protamine-H.
CONCLUSIONS: Exogenous GAG's are effective in providing an epithelial permeability barrier in protamine pretreated bladders. There is a difference in the relative efficacy of the various GAG's in producing this effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679938

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Interstitial cystitis. Etiology, diagnosis, and treatment.

Authors:  J C Nickel
Journal:  Can Fam Physician       Date:  2000-12       Impact factor: 3.275

Review 2.  Urinary bladder, cystitis and nerve/urothelial interactions.

Authors:  Lori A Birder
Journal:  Auton Neurosci       Date:  2013-12-25       Impact factor: 3.145

3.  Interstitial cystitis: characterization and management of an enigmatic urologic syndrome.

Authors:  J Curtis Nickel
Journal:  Rev Urol       Date:  2002

4.  The role of pentosan polysulfate in treatment approaches for interstitial cystitis.

Authors:  Joel Mh Teichman
Journal:  Rev Urol       Date:  2002

5.  The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy.

Authors:  Matthew O Fraser; John P Lavelle; Michael S Sacks; Michael B Chancellor
Journal:  Rev Urol       Date:  2002

6.  A murine model of inflammatory bladder disease: cathelicidin peptide induced bladder inflammation and treatment with sulfated polysaccharides.

Authors:  Siam Oottamasathien; Wanjian Jia; Lindsi McCoard; Sean Slack; Jianxing Zhang; Aleksander Skardal; Kathleen Job; Thomas P Kennedy; Randal O Dull; Glenn D Prestwich
Journal:  J Urol       Date:  2011-08-19       Impact factor: 7.450

7.  Intravesical oxybutynin affects bladder permeability.

Authors:  A Ersay; O C Demirtas
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 8.  Intravesical treatments of bladder cancer: review.

Authors:  Zancong Shen; Tong Shen; M Guillaume Wientjes; Michael A O'Donnell; Jessie L-S Au
Journal:  Pharm Res       Date:  2008-03-28       Impact factor: 4.200

9.  Liposomal inhibition of acrolein-induced injury in rat cultured urothelial cells.

Authors:  J Nirmal; A S Wolf-Johnston; M B Chancellor; P Tyagi; M Anthony; J Kaufman; L A Birder
Journal:  Int Urol Nephrol       Date:  2014-05-30       Impact factor: 2.370

10.  Virtual measurements of paracellular permeability and chronic inflammation via color coded pixel-wise T1 mapping.

Authors:  Nishant Singh; Irina Zabbarova; Youko Ikeda; Jodi Maranchie; Christopher Chermansky; Lesley Foley; T Kevin Hitchens; Naoki Yoshimura; Anthony Kanai; Jonathan Kaufman; Pradeep Tyagi
Journal:  Am J Physiol Renal Physiol       Date:  2020-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.